Drug Discovery Masterclass for Academics
WuXi AppTec is pleased to participate in the Industry Drug Discovery and Development: Strategic Learning with a Focus on Neurodegeneration, taking place on July 10, 2026, in London, United Kingdom. Hosted by University College London (UCL) in conjunction with the 75th Anniversary of the UCL Queen Square Institute of Neurology, this one-day industry masterclass brings together researchers, clinicians, biotechnology companies, pharmaceutical organizations, investors, and industry leaders to explore the interdisciplinary process of advancing neurodegenerative therapies from discovery to clinical development.
The program features presentations from industry experts covering the full drug discovery and development journey, including target identification, lead optimization, translational science, regulatory strategy, commercialization, and clinical development. Through keynote presentations, executive panel discussions, and networking opportunities, attendees will gain valuable insights into the collaborative expertise required to translate innovative neuroscience research into new therapies for patients.
At WuXi AppTec, we support neuroscience drug discovery with integrated capabilities spanning biology, research chemistry, DMPK, pharmacology, preclinical development, laboratory testing, and CMC. By bringing together multidisciplinary expertise across the drug discovery and development continuum, we help partners efficiently advance innovative therapies for neurodegenerative and other central nervous system (CNS) disorders from early research through clinical development.
We look forward to connecting with the neuroscience and drug discovery community in London and discussing how WuXi AppTec can help accelerate your neurodegeneration research and development programs.
To schedule a dedicated meeting with our team, please fill out the form on the right.
Resource Links
Research Chemistry Services
Resource Type: Brochure
WuXi AppTec Biology Services
Resource Type: Brochure
